| Product NDC: | 0085-1402 |
| Proprietary Name: | Foradil |
| Non Proprietary Name: | formoterol fumarate |
| Active Ingredient(s): | 12 ug/1 & nbsp; formoterol fumarate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0085-1402 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020831 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010216 |
| Package NDC: | 0085-1402-01 |
| Package Description: | 12 BLISTER PACK in 1 BOX, UNIT-DOSE (0085-1402-01) > 1 CAPSULE in 1 BLISTER PACK (0085-1402-02) |
| NDC Code | 0085-1402-01 |
| Proprietary Name | Foradil |
| Package Description | 12 BLISTER PACK in 1 BOX, UNIT-DOSE (0085-1402-01) > 1 CAPSULE in 1 BLISTER PACK (0085-1402-02) |
| Product NDC | 0085-1402 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | formoterol fumarate |
| Dosage Form Name | CAPSULE |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20010216 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | FORMOTEROL FUMARATE |
| Strength Number | 12 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |